Surya Pharmaceuticals Ltd. - Research Center
532516 SURYAPHARM Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 14 | Mar ' 13 | Mar ' 12 | Mar ' 11 | Mar ' 10 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 12.64 | 60.33 | 1,622.95 | 1,600.42 | 1,141.66 |
| Expenses | |||||
| Material consumed | 627.45 | 182.90 | 1,661.51 | 1,235.05 | 888.41 |
| Manufacturing expenses | - | 4.93 | 31.72 | 36.84 | 23.85 |
| Personnel expenses | 1.96 | 8.85 | 40.91 | 40.36 | 28.94 |
| Selling expenses | - | - | - | - | 15.80 |
| Adminstrative expenses | 17.73 | 20.64 | 43.59 | 34.80 | 13.48 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 647.14 | 217.32 | 1,777.73 | 1,347.05 | 970.47 |
| Operating profit | -634.51 | -156.98 | -154.78 | 253.37 | 171.18 |
| Other recurring income | 0.47 | -17.64 | -37.98 | 2.67 | 0.31 |
| Adjusted PBDIT | -634.04 | -174.62 | -192.76 | 256.04 | 171.49 |
| Financial expenses | 254.79 | 203.69 | 165.85 | 97.78 | 62.53 |
| Depreciation | 62.63 | 62.47 | 34.62 | 26.55 | 20.55 |
| Other write offs | - | - | - | - | 0.60 |
| Adjusted PBT | -951.45 | -440.78 | -393.22 | 131.72 | 87.81 |
| Tax charges | -443.85 | -156.90 | -120.72 | 31.56 | 14.40 |
| Adjusted PAT | -507.60 | -283.88 | -272.50 | 100.16 | 73.41 |
| Non recurring items | -219.17 | -17.93 | - | - | 2.65 |
| Other non cash adjustments | - | - | - | - | -0.52 |
| Reported net profit | -726.77 | -301.81 | -272.50 | 100.16 | 75.54 |
| Earnigs before appropriation | -726.77 | -233.79 | 68.67 | 345.67 | 75.54 |
| Equity dividend | - | - | - | - | 1.88 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 0.30 |
| Retained earnings | -726.77 | -233.79 | 68.67 | 345.67 | 73.37 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis